rs149939736
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 6P and 4B. PM1PM2PM5BP4_Strong
The NM_000543.5(SMPD1):c.1675G>A(p.Val559Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000541 in 1,614,102 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V559A) has been classified as Uncertain significance.
Frequency
Consequence
NM_000543.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SMPD1 | NM_000543.5 | c.1675G>A | p.Val559Ile | missense_variant | 6/6 | ENST00000342245.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SMPD1 | ENST00000342245.9 | c.1675G>A | p.Val559Ile | missense_variant | 6/6 | 1 | NM_000543.5 | P3 |
Frequencies
GnomAD3 genomes AF: 0.000480 AC: 73AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000485 AC: 122AN: 251490Hom.: 0 AF XY: 0.000471 AC XY: 64AN XY: 135920
GnomAD4 exome AF: 0.000547 AC: 800AN: 1461886Hom.: 0 Cov.: 34 AF XY: 0.000550 AC XY: 400AN XY: 727242
GnomAD4 genome AF: 0.000480 AC: 73AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.000538 AC XY: 40AN XY: 74370
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 06, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden | Nov 03, 2021 | - - |
Niemann-Pick disease, type A;C0268243:Niemann-Pick disease, type B Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 22, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 16, 2024 | - - |
SMPD1-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 24, 2024 | The SMPD1 c.1675G>A variant is predicted to result in the amino acid substitution p.Val559Ile. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.090% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Of note, a different variant impacting the same amino acid (p.Val559Leu) has been reported in the compound heterozygous state in a patient with sphingomyelinase deficiency and measurement of acid sphingomyelinase activity was supportive of a mild defect (Patient 18, Zhang et al. 2013. PubMed ID: 23356216). At this time, the clinical significance of the c.1675G>A (p.Val559Ile) variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Niemann-Pick disease, type A Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 17, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at